Share this
SEC Proposes Watershed Climate-Related Disclosure Requirements
Cooley Alert • April 15, 2022
Origin to List on Nasdaq via SPAC Merger With Artius
March 2, 2021
ASLAN Pharmaceuticals – $42 Million IPO
First Taipei Exchange-listed company to go public in US • June 8, 2018
Fintech Company Kyriba Attracts $45 Million
October 13, 2017
Cooley Advises on Series of Life Sciences IPOs
Zymeworks, Verona, UroGen and Biohaven IPOs highlight core strengths across the sector • May 30, 2017
Bellicum – $69 Million Public Offering
April 5, 2017
Anthera – $15 Million Shelf-Takedown Offering
March 22, 2017
Kite Pharma – $410 Million Shelf‑Takedown Offering
Dermira – $194 Million Shelf-Takedown
March 10, 2017
Cidara – $28 Million Follow-On Offering
October 21, 2016
Dermira – $145 Million Follow-On Offering
June 23, 2016
Cardioxyl Sells to Bristol-Myers Squibb for up to $2 Billion
November 5, 2015
Cidara Completes its Initial Public Offering
April 24, 2015
Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering
March 30, 2015
Bellicum Completes $160 Million Initial Public Offering
February 13, 2015
Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes
December 2, 2014